Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results hospitalization Esymptomatic Covid-19 Econfirmed COVID (any severity) E

COVID-19 prophylaxis (excluding children) meta-analysis

BNT162b2 phase 3 (C4591001, Polack)
 
NCT04368728
RCTComirnaty (tozinameran - Pfizer/BIONTECH)placeboCOVID-19 prophylaxis (excluding children)some concern
21720/21728 conclusif demonstrated-85%
COVE Moderna/NIH phase 3 (study 301)
 
NCT04470427
RCTSpikevax (Moderna mRNA-1273 COVID-19 vaccine)placeboCOVID-19 prophylaxis (excluding children)some concern
15181/15170 conclusif demonstrated-85%
Moderna study 201 100µg
 
NCT04405076
RCTSpikevax (Moderna mRNA-1273 COVID-19 vaccine)placeboCOVID-19 prophylaxis (excluding children)NA
189/186 no results
Nguyen OBSComirnaty (tozinameran - Pfizer/BIONTECH)Vaxzevria (AstraZeneca Oxford - ChAdOx1 nCoV-19)COVID-19 prophylaxis (excluding children)NA
-/- inconclusive -1%
Amit OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
7214/1895 suggested
Dagan OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
596618/596618 suggested -78% -85%
SIREN (HW england)
 
ISRCTN11041050
OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)serious
-/- suggested
Thompson OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)critical
2961/989 suggested -81%
Agur unpublished OBSmRNA vaccineuncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results
Scotland cohort unpublished OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested
Shemer OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- inconclusive
Shemer OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)NA
-/- inconclusive
Thompson -VISIOn Network (omicron) OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)NA
-/- suggested -73% -47% -47%
Husby (Moderna) OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)NA
-/- safety concern
Husby (pfizer) OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- inconclusive
Patone OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- safety concern
Shasha OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- safety concern
Kirsebom (UKHSA) OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)NA
-/- suggested -16%
Angel OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
5517/757 suggested -87%
Barda OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)critical
-/- safety concern
Bernal (PHE, 19th February 2021) OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested -55%
Bjork OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested -77%
Chodcik OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)serious
503875/351897 inconclusive
EPI-PHARE OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)critical
-/- inconclusive
Goldberg OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested -85%
Haas OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested -87% -87%
Heymann OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested -80%
Klein OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)critical
-/- suggested
Klein OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)critical
-/- suggested
Mayo Clinic (Puranik) OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)serious
51738/25869 suggested -73% -68%
Mayo Clinic (Puranik) OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)serious
51738/25869 suggested -68% -38%
McMurry OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested
McMurry OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested
Nanduri OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)serious
-/- suggested -46%
Nanduri OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)serious
-/- suggested -47%
Pawlowski OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- inconclusive
Shibli OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- safety concern
Shibli OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)NA
-/- safety concern
Tartof
 
NCT04848584
OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (children), COVID-19 prophylaxis (excluding children)NA
-/- suggested -81% -66%
Weekes OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested
Tande unpublished OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)NA
-/- no results
Lauring OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)NA
5728/5962 suggested -76%
Southern California (Tseng) - delta OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested -86%
Southern California (Tseng) - omicron OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested -27%
Tenforde OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)NA
-/- suggested -74%
Abu-Raddad OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- no results -81%
Chung OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)NA
53270/270763 suggested -85%
Chung OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
53270/270763 suggested -82%
Chung OBSmRNA vaccinecontrolCOVID-19 prophylaxis (excluding children)NA
53270/270763 suggested -82%
England (Andrews) OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
581/130867 suggested -44% -44%
Qatar (Tang) OBSSpikevax (Moderna mRNA-1273 COVID-19 vaccine)controlCOVID-19 prophylaxis (excluding children)serious
-/- suggested -76%
Qatar (Tang) OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)serious
-/- suggested -48%
South Africa (Discovery Health, Collie) OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)NA
-/- suggested -63% -45% -45%
Tenforde OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)serious
1194/1895 suggested -76%
Wan OBSComirnaty (tozinameran - Pfizer/BIONTECH)controlCOVID-19 prophylaxis (excluding children)critical
-/- safety concern
Aleman DESCmRNA vaccineuncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results
Benotmane DESCSpikevax (Moderna mRNA-1273 COVID-19 vaccine)uncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results
Boyarsky DESCmRNA vaccineuncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results
Palich DESCComirnaty (tozinameran - Pfizer/BIONTECH)uncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results
Rozen-Zvi DESCComirnaty (tozinameran - Pfizer/BIONTECH)uncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results
Yanay DESCComirnaty (tozinameran - Pfizer/BIONTECH)uncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results
Zadok DESCComirnaty (tozinameran - Pfizer/BIONTECH)uncontrolled studyCOVID-19 prophylaxis (excluding children)NA
-/- no results

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).